Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

    Results: 1 to 20 of 41

    1.

    Verbal Memory Deficits Are Correlated with Prefrontal Hypometabolism in (18)FDG PET of Recreational MDMA Users.

    Bosch OG, Wagner M, Jessen F, Kühn KU, Joe A, Seifritz E, Maier W, Biersack HJ, Quednow BB.

    PLoS One. 2013 Apr 9;8(4):e61234. doi: 10.1371/journal.pone.0061234. Print 2013.

    PMID:
    23585882
    [PubMed - in process]
    Free PMC Article
    2.

    Neural correlates of the severity of cocaine, heroin, alcohol, MDMA and cannabis use in polysubstance abusers: a resting-PET brain metabolism study.

    Moreno-López L, Stamatakis EA, Fernández-Serrano MJ, Gómez-Río M, Rodríguez-Fernández A, Pérez-García M, Verdejo-García A.

    PLoS One. 2012;7(6):e39830. doi: 10.1371/journal.pone.0039830. Epub 2012 Jun 29.

    PMID:
    22768136
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Imaging DA release in a rat model of L-DOPA-induced dyskinesias: a longitudinal in vivo PET investigation of the antidyskinetic effect of MDMA.

    Lettfuss NY, Fischer K, Sossi V, Pichler BJ, von Ameln-Mayerhofer A.

    Neuroimage. 2012 Oct 15;63(1):423-33. doi: 10.1016/j.neuroimage.2012.06.051. Epub 2012 Jul 2.

    PMID:
    22766162
    [PubMed - indexed for MEDLINE]
    4.

    Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.

    Urban NB, Girgis RR, Talbot PS, Kegeles LS, Xu X, Frankle WG, Hart CL, Slifstein M, Abi-Dargham A, Laruelle M.

    Neuropsychopharmacology. 2012 May;37(6):1465-73. doi: 10.1038/npp.2011.332. Epub 2012 Feb 22.

    PMID:
    22353758
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Characterization of 4-[18F]-ADAM as an imaging agent for SERT in non-human primate brain using PET: a dynamic study.

    Chen YA, Huang WS, Lin YS, Cheng CY, Liu RS, Wang SJ, Li IH, Huang SY, Shiue CY, Chen CY, Ma KH.

    Nucl Med Biol. 2012 Feb;39(2):279-85. doi: 10.1016/j.nucmedbio.2011.08.002. Epub 2011 Dec 1.

    PMID:
    22136885
    [PubMed - indexed for MEDLINE]
    6.

    Differential effects of cocaine and MDMA self-administration on cortical serotonin transporter availability in monkeys.

    Gould RW, Gage HD, Banks ML, Blaylock BL, Czoty PW, Nader MA.

    Neuropharmacology. 2011 Jul-Aug;61(1-2):245-51. doi: 10.1016/j.neuropharm.2011.04.007. Epub 2011 Apr 17.

    PMID:
    21521647
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA ('Ecstasy'): an 18F-dopa PET study.

    Tai YF, Hoshi R, Brignell CM, Cohen L, Brooks DJ, Curran HV, Piccini P.

    Neuropsychopharmacology. 2011 Mar;36(4):735-43. doi: 10.1038/npp.2010.201. Epub 2010 Dec 15.

    PMID:
    21160467
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    MDMA-evoked changes in the binding of dopamine D(2) receptor ligands in striatum of rats with unilateral serotonin depletion.

    Ostergaard SD, Alstrup AK, Gramsbergen JB, Minuzzi L, Pedersen K, Jensen SB, Doudet D, Cumming P.

    Synapse. 2010 Jan;64(1):70-82. doi: 10.1002/syn.20706.

    PMID:
    19768811
    [PubMed - indexed for MEDLINE]
    9.

    Study on the neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PET.

    Li IH, Huang WS, Shiue CY, Huang YY, Liu RS, Chyueh SC, Hu SH, Liao MH, Shen LH, Liu JC, Ma KH.

    Neuroimage. 2010 Jan 15;49(2):1259-70. doi: 10.1016/j.neuroimage.2009.07.072. Epub 2009 Aug 12.

    PMID:
    19682588
    [PubMed - indexed for MEDLINE]
    10.

    Brain serotonin transporter binding in former users of MDMA ('ecstasy').

    Selvaraj S, Hoshi R, Bhagwagar Z, Murthy NV, Hinz R, Cowen P, Curran HV, Grasby P.

    Br J Psychiatry. 2009 Apr;194(4):355-9. doi: 10.1192/bjp.bp.108.050344.

    PMID:
    19336788
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    Hippocampal remodelling after MDMA neurotoxicity: a single case study.

    Nifosì F, Martinuzzi A, Toffanin T, Costanzo R, Vestri A, Battaglia M, Bertagnoni GE, Lupi A, Amistà P, Carollo C, Perini G.

    World J Biol Psychiatry. 2009;10(4 Pt 3):961-8. doi: 10.1080/15622970701870933.

    PMID:
    18609419
    [PubMed - indexed for MEDLINE]
    12.

    In vivo pharmacology of MDMA and its enantiomers in rhesus monkeys.

    Fantegrossi WE.

    Exp Clin Psychopharmacol. 2008 Feb;16(1):1-12. doi: 10.1037/1064-1297.16.1.1.

    PMID:
    18266547
    [PubMed - indexed for MEDLINE]
    13.

    Imaging the neurochemistry of alcohol and substance abuse.

    Martinez D, Kim JH, Krystal J, Abi-Dargham A.

    Neuroimaging Clin N Am. 2007 Nov;17(4):539-55, x. Review.

    PMID:
    17983969
    [PubMed - indexed for MEDLINE]
    14.

    Effects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys.

    Banks ML, Czoty PW, Gage HD, Bounds MC, Garg PK, Garg S, Nader MA.

    Neuropsychopharmacology. 2008 Jan;33(2):219-25. Epub 2007 Apr 18.

    PMID:
    17443127
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    A PET study of effects of chronic 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on serotonin markers in Göttingen minipig brain.

    Cumming P, Møller M, Benda K, Minuzzi L, Jakobsen S, Jensen SB, Pakkenberg B, Stark AK, Gramsbergen JB, Andreasen MF, Olsen AK.

    Synapse. 2007 Jul;61(7):478-87.

    PMID:
    17415793
    [PubMed - indexed for MEDLINE]
    16.

    Effects of MDMA on blood glucose levels and brain glucose metabolism.

    Soto-Montenegro ML, Vaquero JJ, Arango C, Ricaurte G, García-Barreno P, Desco M.

    Eur J Nucl Med Mol Imaging. 2007 Jun;34(6):916-25. Epub 2007 Jan 12.

    PMID:
    17219137
    [PubMed - indexed for MEDLINE]
    17.

    Ecstasy-induced reduction of the availability of the brain serotonin transporter as revealed by [11C](+)McN5652-PET and the multi-linear reference tissue model: loss of transporters or artifact of tracer kinetic modelling?

    Buchert R, Thiele F, Thomasius R, Wilke F, Petersen K, Brenner W, Mester J, Spies L, Clausen M.

    J Psychopharmacol. 2007 Aug;21(6):628-34. Epub 2006 Nov 8.

    PMID:
    17092972
    [PubMed - indexed for MEDLINE]
    18.

    Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.

    Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ.

    J Psychopharmacol. 2006 Mar;20(2):164-75. Review.

    PMID:
    16510475
    [PubMed - indexed for MEDLINE]
    19.

    Radioligands for the study of the 5-HT transporter in vivo.

    Brust P, Scheffel U, Szabo Z.

    IDrugs. 1999 Feb;2(2):129-45.

    PMID:
    16160948
    [PubMed]
    20.

    Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.

    McCann UD, Szabo Z, Seckin E, Rosenblatt P, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA.

    Neuropsychopharmacology. 2005 Sep;30(9):1741-50.

    PMID:
    15841106
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk